HTLD 241220 2.50P (HTLD241220P2500) Stock Options, News & Quotes

0.01
0.000.00%

15min DelayTrading Apr 30 11:35 ET

0.00High0.00Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Feb 3 06:52

Analysts turn bearish after recent results, leading to reduced revenue forecasts and a significant cut in EPS estimates. Despite forecast cuts, the price target remains unchanged, implying the changes don't significantly impact intrinsic value. The company's revenues are expected to underperform the wider industry.

Heartland Express, Inc. Just Recorded A 372% EPS Beat: Here's What Analysts Are Forecasting Next

Moomoo AI

Jan 4 09:07

The future decline in revenue growth is worrisome despite the company's strong past performance. The P/S ratio, similar to the industry average, indicates possibly unsustainable current price levels considering the bleak revenue outlook.

Heartland Express, Inc.'s (NASDAQ:HTLD) Share Price Not Quite Adding Up

Moomoo AI

Dec 13, 2023 05:28

Insider purchases show confidence in Heartland Express's future, implying a correlation between insiders and other shareholders. The high price for earlier shares indicates insiders saw value even at a premium.

Heartland Express Chairman of the Board Acquires 4.7% More Stock

Moomoo AI

Nov 25, 2023 06:37

The recent insider purchases suggest a positive outlook and strong confidence about the future of Heartland Express, Inc. The significant level of insider ownership indicates that the management's interest aligns with that of the shareholders.

Chairman of the Board of Heartland Express Michael Gerdin Buys 1.2% More Shares

Analysts Notebook

Mar 15, 2022 06:27

Columns Top upgrades and downgrades on 3/15

Upgrades
• $Ascendis Pharma A/S (ASND.US)$: BofA Securities Upgrades to Buy from Neutral - PT $161 (from $148)
• $GoodRx (GDRX.US)$: Baird Upgrades to Outperform from Neutral - PT $17
• $W.W. Grainger (GWW.US)$: Atlantic Equities Upgrades to Overweight from Neutral - PT $580 (from $520)
• $Heartland Express (HTLD.US)$: Morgan Stanley Upgrades to Equalweight from Underweight - PT $16
• $The Mosaic (MOS.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $83
• $Northern Oil & Gas (NOG.US)$: Johnson ...